TL;DR
Get business pricing on networking and server gear
- Business-only prices and quantity discounts
- Tax-exempt purchasing
- Multiple users, one account, clear invoices
In an interview published by The Quantum Insider on Oct. 3, 2026, 55North general partner Helmut Katzgraber said near- to medium-term quantum computing applications are more likely in simulating materials, chemicals and pharmaceutical compounds than in optimization. He described optimization as an area where classical computing is likely to remain ahead for the foreseeable future, while stressing that practical quantum advantage has yet to be established.
Helmut Katzgraber, a general partner at quantum-focused venture fund 55North and former quantum leader at AWS, said quantum computing’s most promising near- to medium-term uses are likely to be simulations of materials, chemicals and pharmaceutical compounds, rather than optimization. In an interview published by The Quantum Insider on Oct. 3, 2026, he argued that quantum hardware is better matched to problems governed by quantum mechanics, while classical methods are likely to outperform quantum devices on optimization for the foreseeable future.
Katzgraber said the clearest prospective opportunity lies in simulating systems where classical computers struggle, including strongly correlated materials. He cited battery materials, organic LEDs and some medicines involving metal-organic complexes as examples. His comments describe a view about where useful applications may emerge; they do not establish that quantum computers can already outperform classical computers on these tasks in production settings.
He pointed to a recent paper involving a material simulated on a neutral-atom machine as an example of the research direction. The interview did not identify the paper, its results or a classical comparison in enough detail to assess what advantage, if any, the experiment demonstrated. Katzgraber also called machine learning a nascent area where he was not ready to make a firm prediction.
As an investor, Katzgraber said 55North sees opportunities beyond quantum processors themselves. He named refrigeration technologies needed by different hardware approaches and software for calculating error-correction models as potential areas with nearer-term commercial prospects. He said some companies may produce returns within a venture fund’s lifetime, while other quantum technologies could take longer to mature.
Why Simulation Fits Quantum Hardware
Katzgraber’s distinction matters because it directs attention away from a broad promise that quantum computers will improve every hard computational task. His case is that machines based on quantum physics may be most naturally applied to modeling quantum systems, including molecules and materials, rather than to general-purpose search or optimization. That framing can help customers and investors judge claims against the specific problems a device is designed to address.
The potential payoff is relevant to industries that develop batteries, electronic materials and medicines. Better simulations could, if they become accurate and practical, help researchers examine candidate compounds or material properties. But the interview presents this as a prospective opportunity, not a demonstrated reduction in development time or cost. The gap between a laboratory result and a dependable commercial workflow remains central.
His investment comments also broaden the discussion: commercial activity need not wait for a fault-tolerant quantum computer if companies can sell useful enabling products first. Still, Katzgraber’s examples are an investor’s assessment of possible opportunities, not evidence that every named category has established demand or predictable returns.
quantum simulation software for materials
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Research Labs to Products
Katzgraber previously led a quantum science team at AWS and has held academic and industry roles, according to the interview. He told interviewer Yuval Boger that his experience over several years at Microsoft and AWS shaped his assessment of what quantum machines can and cannot do. He now works at 55North, a Denmark-based venture fund focused on quantum technologies.
The interview also addressed Europe’s ability to compete with the United States and China. Katzgraber said Europe has strong research talent, universities and publicly supported laboratory ecosystems, but that the route from scientific ideas to commercial products is a weak point. That observation connects the technical debate to a practical challenge: producing a promising simulation is not the same as building a product customers can use.
The article’s central argument is not that optimization has no possible quantum applications. Rather, Katzgraber said he expects classical technologies to remain ahead there for the foreseeable future, while quantum simulation offers a closer fit between the physics of the machine and the target problem.
“Use quantum where quantum reigns supreme, you know, in the quantum world.”
— Helmut Katzgraber, 55North general partner, in an interview with Yuval Boger
quantum chemistry simulation tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence Still Falls Short of Advantage
The interview does not establish that quantum simulation has delivered a practical advantage over classical computing for the cited materials, chemical or pharmaceutical problems. It refers to a recent neutral-atom simulation paper but gives no study title, performance figures, benchmark methodology or details about whether the result could be used in an industrial workflow.
It also remains unclear when quantum devices might deliver commercial value for these applications, which hardware platforms will prove useful, and how costs and accuracy will compare with classical approaches. Katzgraber’s views on optimization, investment timelines and Europe’s commercialization challenges are his assessments; the interview supplies no independent market data or comparative analysis to verify them.
quantum computing for pharmaceutical research
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Benchmarks and Products to Watch
The next test for the simulation thesis will be whether research teams can demonstrate results on relevant materials or molecules that are difficult to obtain classically, with transparent comparisons and a clear path to useful applications. The source interview does not announce a specific upcoming benchmark, product launch or commercial milestone.
For investors and potential users, subsequent evidence will include the performance of quantum hardware and enabling tools such as refrigeration and error-correction software, alongside progress in turning laboratory work into customer-ready products. Katzgraber said machine learning remains too nascent for him to make a firm call and expects classical methods to retain an advantage in optimization for the foreseeable future.
quantum hardware refrigeration systems
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What quantum applications does Katzgraber see as most promising?
He favors quantum simulation for materials, chemicals and pharmaceutical compounds, particularly systems where classical computation struggles.
Does the interview show that quantum computers already outperform classical computers?
No. It describes Katzgraber’s expectations and refers to a neutral-atom simulation paper, but provides no benchmark details establishing a practical quantum advantage.
What is Katzgraber’s view of quantum optimization?
He said he expects classical technologies to outperform quantum devices on optimization for the foreseeable future. This is his assessment, not a claim that every optimization problem has been settled.
What investment opportunities did he identify?
He cited enabling technologies such as refrigeration and software for error-correction calculations, which he said could have nearer-term commercial prospects than some quantum applications.
What challenge did he identify for Europe’s quantum sector?
Katzgraber praised Europe’s research talent and laboratory ecosystem but said the pipeline from research ideas to marketable products is weak. The interview did not provide comparative figures to quantify that gap.
Source: rss
Columbus Day / Indigenous Peoples' Day Picks
long weekend sales
As an affiliate, we earn on qualifying purchases.
